Stocks to Watch - DVAX, VSAT, ISIS, LLY.

0 Comments | M2 Presswire, December, 2006

M2 PRESSWIRE-11 December 2006-SmallCapReview: Stocks to Watch - DVAX, VSAT, ISIS, LLY(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:11122006 Dynavax Technologies (Nasdaq: DVAX) Closed at $9.54. Announced preliminary data from an ongoing open label Phase 2a study of the company's TLR9 agonist used in combination with rituximab as a treatment for patients with non-Hodgkin's lymphoma.

The study enrolled 23 follicular lymphoma patients who had relapsed after at least one prior treatment. Patients were evaluated using functional assays, gene expression profiling and immunohistochemistry studies. Dr. Friedberg indicated that patients treated with the TLR9 agonist who had clearly increased expression of TLR9 agonist- and interferon-inducible genes showed a prolonged...

Read the rest of this article with a Free Trial at HighBeam Research.
Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:
  1. You are currently: a Guest |
  4.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)